The emergence of supportive oncodermatology: The study of dermatologic adverse events to cancer therapies Journal Article
| Authors: | Balagula, Y.; Rosen, S. T.; Lacouture, M. E. |
| Article Title: | The emergence of supportive oncodermatology: The study of dermatologic adverse events to cancer therapies |
| Abstract: | Cancer therapies have led to remarkable results due to improved toxicity profiles and effects on survival. While these medical, surgical, and radiation protocols are chiefly responsible for these noteworthy contributions, an unexpected constellation of toxicities has emerged. Most notably, dermatologic adverse events have gained considerable attention, due to their high frequency, visibility, and impact on physical and psychosocial health, all of which affect dose intensity and possibly clinical outcome. Consequently, increased attention to cutaneous health in oncology has resulted in supportive oncodermatology clinical programs and toxicity-driven investigations, aiming to mitigate these untoward events and permit the continued optimization of cancer treatments. © 2010 by the American Academy of Dermatology, Inc. |
| Keywords: | cancer chemotherapy; cancer surgery; acute granulocytic leukemia; fludarabine; review; cytotoxic agent; doxorubicin; erlotinib; fluorouracil; cancer combination chemotherapy; drug dose reduction; drug withdrawal; side effect; capecitabine; gemcitabine; paclitaxel; cancer patient; cancer radiotherapy; cytarabine; topotecan; outcome assessment; antineoplastic agent; imatinib; unindexed drug; edema; quality of life; drug eruption; actinic keratosis; mucosa inflammation; randomized controlled trial; stomatitis; epidermal growth factor receptor; vincristine; food and drug administration; radiation injury; oncology; cetuximab; hyperkeratosis; psoriasis; chlormethine; vinblastine; docetaxel; irinotecan; panitumumab; pruritus; postoperative complication; lymphedema; health program; maculopapular rash; skin exfoliation; adverse outcome; gefitinib; daunorubicin; graft versus host reaction; erythema; hyperpigmentation; hair disease; nail; skin lupus erythematosus; telangiectasia; lymphoproliferative disease; idarubicin; egfr; navelbine; hand foot syndrome; lymphatic drainage; alopecia; pemetrexed; mycosis fungoides; photosensitivity; lapatinib; mitotane; drug induced disease; radiation dermatitis; urticaria; skin care; phlebitis; kinesiotherapy; desquamation; lichenoid eruption; paronychia; scalp hair; skin fissure; stevens johnson syndrome; toxic epidermal necrolysis; xerosis; cladribine; skin atrophy; tegafur; hypopigmentation; low level laser therapy; self care; randomized controlled trial (topic); pyogenic granuloma; onycholysis; pigment disorder; subungual hemorrhage; trichomegaly; erythema multiforme; fat necrosis; skin edema; qol; skin fibrosis; vasculitis; epidermal growth factor receptor inhibitor; extravasation; chemotherapy-induced alopecia; cia; egfri; fda; hand-foot skin reaction; hand-foot syndrome; hfs; hfsr; mascc; multinational association for supportive care in cancer; rct; pyridoxine; acral erythema; acral hyperpigmentation; acute febrile neutrophilic dermatosis; acute generalized exanthematous pustulosis; acute radiation dermatitis; b cell lymphoproliferative disorder; body hair; brittle nail; bullous skin disease; chemotherapy induced alopecia; compression bandage; eccrine squamous syringometaplasia; erysipelas; erythema nodosum; follicle mucinosis; hair curling; hair growth; hidradenitis; linear immunoglobulin a bullous dermatosis; lipodermatosclerosis; manual lymphatic drainage; melanocytic macule; melanonychia; mucosal hyperpigmentation; nail dystrophy; nail hyperpigmentation; neutrophic eccrine hidradenitis; neutrophilic eccrine hidradenitis; oral lichenoid eruption; palm erythema; palmoplantar keratoderma; papulopustular eruption; paraneoplastic pemphigus; photoallergy; photolichenoid eruption; photosensitivity disorder; pityriasis lichenoides; pityriasis rosea; porphyria cutanea tarda; pseudolymphoma; psoriasiform acral hyperkeratosis; radiation enhancement; radiation recall; scleroderma; small vessel vasculitis; sole erythema; supportive oncodermatology; ultraviolet recall; urticarial vasculitis; varioliformis acuta |
| Journal Title: | Journal of the American Academy of Dermatology |
| Volume: | 65 |
| Issue: | 3 |
| ISSN: | 0190-9622 |
| Publisher: | Mosby Elsevier |
| Date Published: | 2011-01-01 |
| Start Page: | 624 |
| End Page: | 635 |
| Language: | English |
| DOI: | 10.1016/j.jaad.2010.06.051 |
| PROVIDER: | scopus |
| PUBMED: | 21777992 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 3 October 2011" - "CODEN: JAADD" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work